Showing results (131-140 of 201) with videos related to
Sort By:
Pageof 21
European Journal of Immunology|July 13, 2001
The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell wallsU K Hanisch, M Prinz, K Angstwurm, et al.International Archives of Allergy and Immunology|September 1, 2006
A cutaneous allergen neutralisation test that correlates with the duration of venom immunotherapyGabriela Senti, Pål Johansen, Ruben Oliver, et al.Science (New York, N.Y.)|December 11, 1976
Mineralogic and petrologic implications of viking geochemical results from Mars: interim reportA K Baird, P Toulmin, B C Clark, et al.Journal of Cutaneous Pathology|July 9, 2002
Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditionsDmitry V Kazakov, Bettina M Prinz, Sonja Michaelis, et al.Journal of Neuropathology and Experimental Neurology|October 9, 1999
Microglial activation by components of gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokinesM Prinz, O Kann, H J Draheim, et al.Human Brain Mapping|April 22, 2010
Selective attention to face identity and color studied with f MRIV P Clark, R Parasuraman, K Keil, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 9, 2012
[Pediatric fracture diagnosis--ultra-low-dose CT with an effective dose equal to that of radiographs]J D Moritz, B Hoffmann, D H Sehr, et al.Journal of Forensic Sciences|December 3, 1999
Frequencies of D8S384 alleles and genotypes in European, African-American, Chinese, and Japanese populationsH Y Meng, Y P Hou, G D Chen, et al.Frontiers in Allergy|April 7, 2022
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in HumansAlexandra Chabot, Gabriela Senti, Iris Erdmann, et al.European Journal of Drug Metabolism and Pharmacokinetics|February 28, 2022
Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy IndividualsXiaoxing Wang, Martin E Dowty, Ann Wouters, et al.Pageof 21